Anti-GCNT4 monoclonal antibody

Pre-made anti-GCNT4 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to GCNT4/GCNT4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0894-Ab-1/ GM-Tg-hg-IP0894-Ab-2Anti-Human GCNT4 monoclonal antibodyHuman
GM-Tg-rg-IP0894-Ab-1/ GM-Tg-rg-IP0894-Ab-2Anti-Rat GCNT4 monoclonal antibodyRat
GM-Tg-mg-IP0894-Ab-1/ GM-Tg-mg-IP0894-Ab-2Anti-Mouse GCNT4 monoclonal antibodyMouse
GM-Tg-cynog-IP0894-Ab-1/ GM-Tg-cynog-IP0894-Ab-2Anti-Cynomolgus/ Rhesus macaque GCNT4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0894-Ab-1/ GM-Tg-felg-IP0894-Ab-2Anti-Feline GCNT4 monoclonal antibodyFeline
GM-Tg-cang-IP0894-Ab-1/ GM-Tg-cang-IP0894-Ab-2Anti-Canine GCNT4 monoclonal antibodyCanine
GM-Tg-bovg-IP0894-Ab-1/ GM-Tg-bovg-IP0894-Ab-2Anti-Bovine GCNT4 monoclonal antibodyBovine
GM-Tg-equg-IP0894-Ab-1/ GM-Tg-equg-IP0894-Ab-2Anti-Equine GCNT4 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0894-Ab-1/ GM-Tg-hg-IP0894-Ab-2; GM-Tg-rg-IP0894-Ab-1/ GM-Tg-rg-IP0894-Ab-2;
GM-Tg-mg-IP0894-Ab-1/ GM-Tg-mg-IP0894-Ab-2; GM-Tg-cynog-IP0894-Ab-1/ GM-Tg-cynog-IP0894-Ab-2;
GM-Tg-felg-IP0894-Ab-1/ GM-Tg-felg-IP0894-Ab-2; GM-Tg-cang-IP0894-Ab-1/ GM-Tg-cang-IP0894-Ab-2;
GM-Tg-bovg-IP0894-Ab-1/ GM-Tg-bovg-IP0894-Ab-2; GM-Tg-equg-IP0894-Ab-1/ GM-Tg-equg-IP0894-Ab-2
Products NameAnti-GCNT4 monoclonal antibody
Formatmab
Target NameGCNT4
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-GCNT4 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0894-Ag-1Recombinant multi-species GCNT4/ C2GNT3/ LINC01336 protein


    Target information

    Target IDGM-IP0894
    Target NameGCNT4
    Gene ID51301,218476,120100673,705107,488946,101081604,782825,100073285
    Gene Symbol and SynonymsC2GNT3,GCNT4,Gm279,Gm73,LINC01336,RGD1563891
    Uniprot AccessionQ9P109
    Uniprot Entry NameGCNT4_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000176928
    Target ClassificationN/A

    The target: GCNT4, gene name: GCNT4, also named as C2GNT3, LINC01336. Predicted to enable acetylglucosaminyltransferase activity. Predicted to be involved in O-glycan processing and carbohydrate metabolic process. Predicted to act upstream of or within several processes, including inter-male aggressive behavior; kidney morphogenesis; and thyroid hormone metabolic process. Predicted to be located in Golgi membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.